BNC Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
DAM
F
BNC Wealth Management's NVO Position: Q1 2026 in Review
BNC Wealth Management sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 5,058 shares — an estimated $257K sold.
BNC Wealth Management first reported a position in NVO in Q3 2020 and held it in 22 quarters. The position peaked at $993K in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- BNC Wealth Management reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
- BNC Wealth Management sold 5,058 Novo Nordisk shares in Q1 2026, an estimated $257K.
- BNC Wealth Management first reported a position in Novo Nordisk in Q3 2020 and held it in 22 quarters.
- BNC Wealth Management's Novo Nordisk position peaked at $993K in Q2 2024.
- 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on BNC Wealth Management's 13F filing for Q1 2026, filed 13 Apr 2026.